Evidence map›Paper›PMID 42110980›Full record

ArticleBiomedical optics express2026

Label-free detection of ovarian cancer cells in ascites-related cell models using digital holographic flow cytometry.

Yijing Li, Wen Xiao, Hui Zhang, Xiaoping Li, Feng Pan

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yijing LiKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing 100191, China.
Wen XiaoKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing 100191, China.
Hui ZhangDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Xiaoping LiDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Feng PanKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-3303-4317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer is one of the most lethal gynecological malignancies, frequently accompanied by ascites formation in advanced stages. Accurate identification of ovarian cancer cells within ascitic fluid is clinically important yet technically challenging due to pronounced cellular heterogeneity. Here, we establish a quantitative holographic imaging flow cytometry framework for ovarian cancer cell discrimination under ascites-mimicking conditions using single-cell phase images acquired by microfluidic digital holographic microscopy. A six-cell-type dataset was constructed to emulate the heterogeneous tumor-associated microenvironment, introducing substantial morphological and biophysical overlap. Within this unified experimental setting, we systematically compared multidimensional feature-based machine learning models with end-to-end deep learning approaches to assess their relative performance in cancer cell detection. Deep learning models demonstrated improved robustness and sensitivity in complex backgrounds while preserving high-throughput capability. This study provides a structured evaluation of quantitative phase-driven cell classification and supports the development of rapid, automated, label-free screening strategies for ascites analysis.

Identifiers

PMID42110980
PMCPMC13155843

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.